definitive healthcare corp - DH

DH

Close Chg Chg %
0.91 -0.01 -1.14%

Closed Market

0.90

-0.01 (1.14%)

Volume: 320.79K

Last Updated:

Jun 5, 2026, 4:00 PM EDT

Company Overview: definitive healthcare corp - DH

DH Key Data

Open

$0.93

Day Range

0.86 - 0.95

52 Week Range

0.80 - 4.70

Market Cap

$96.03M

Shares Outstanding

105.52M

Public Float

29.79M

Beta

1.33

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$1.63

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

329.09K

 

DH Performance

1 Week
 
-3.63%
 
1 Month
 
-5.85%
 
3 Months
 
-23.98%
 
1 Year
 
-76.02%
 
5 Years
 
N/A
 

DH Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 11
Full Ratings ➔

About definitive healthcare corp - DH

Definitive Healthcare Corp. engages in the provision of healthcare commercial intelligence. Its solution offers information on healthcare providers and their activities to help the customers optimize from product development to go-to-market planning, sales, and marketing execution. The company was founded by Jason Kranzt in February 2011 and is headquartered in Framingham, MA.

DH At a Glance

Definitive Healthcare Corp.
492 Old Connecticut Path
Framingham, Massachusetts 01701
Phone 1-508-720-4224 Revenue 241.52M
Industry Packaged Software Net Income -138,932,000.00
Sector Technology Services Employees 686
Fiscal Year-end 12 / 2026
View SEC Filings

DH Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 1.267
Price to Book Ratio 1.062
Price to Cash Flow Ratio 5.69
Enterprise Value to EBITDA 11.139
Enterprise Value to Sales 1.639
Total Debt to Enterprise Value 0.436

DH Efficiency

Revenue/Employee 352,071.429
Income Per Employee -202,524.781
Receivables Turnover 4.609
Total Asset Turnover 0.265

DH Liquidity

Current Ratio 1.562
Quick Ratio 1.562
Cash Ratio 1.154

DH Profitability

Gross Margin 61.053
Operating Margin -8.522
Pretax Margin -86.641
Net Margin -57.524
Return on Assets -15.226
Return on Equity -38.30
Return on Total Capital -30.617
Return on Invested Capital -24.728

DH Capital Structure

Total Debt to Total Equity 61.422
Total Debt to Total Capital 38.051
Total Debt to Total Assets 23.476
Long-Term Debt to Equity 57.357
Long-Term Debt to Total Capital 35.532
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Definitive Healthcare Corp - DH

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
222.65M 251.41M 252.20M 241.52M
Sales Growth
+34.00% +12.92% +0.31% -4.24%
Cost of Goods Sold (COGS) incl D&A
82.77M 86.49M 92.35M 94.06M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
56.90M 51.75M 51.67M 56.11M
Depreciation
2.19M 1.95M 2.25M 3.30M
Amortization of Intangibles
54.71M 49.80M 49.42M 52.81M
COGS Growth
+4.29% +4.49% +6.78% +1.85%
Gross Income
139.88M 164.93M 159.85M 147.46M
Gross Income Growth
+61.18% +17.90% -3.08% -7.75%
Gross Profit Margin
+62.83% +65.60% +63.38% +61.05%
2022 2023 2024 2025 5-year trend
SG&A Expense
176.04M 195.84M 169.59M 168.04M
Research & Development
34.89M 42.44M 36.52M 34.78M
Other SG&A
141.15M 153.40M 133.07M 133.26M
SGA Growth
+66.89% +11.25% -13.40% -0.92%
Other Operating Expense
- - - -
-
Unusual Expense
7.89M 298.89M 701.08M 204.19M
EBIT after Unusual Expense
(44.04M) (329.80M) (710.82M) (224.78M)
Non Operating Income/Expense
10.58M 36.82M 91.91M 26.81M
Non-Operating Interest Income
- 13.64M 14.59M 6.95M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
8.41M 15.20M 14.84M 11.29M
Interest Expense Growth
-67.48% +80.71% -2.41% -23.92%
Gross Interest Expense
8.41M 15.20M 14.84M 11.29M
Interest Capitalized
- - - -
-
Pretax Income
(41.88M) (308.18M) (633.75M) (209.26M)
Pretax Income Growth
+30.88% -635.92% -105.64% +66.98%
Pretax Margin
-18.81% -122.58% -251.28% -86.64%
Income Tax
(17.70M) (18.55M) (42.30M) (9.96M)
Income Tax - Current - Domestic
108.00K (91.00K) 110.00K 747.00K
Income Tax - Current - Foreign
- 251.00K 261.00K 172.00K
Income Tax - Deferred - Domestic
(17.06M) (18.43M) (42.51M) (10.97M)
Income Tax - Deferred - Foreign
(742.00K) (280.00K) (156.00K) 95.00K
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(24.18M) (289.63M) (591.45M) (199.30M)
Minority Interest Expense
(16.96M) (87.24M) (178.32M) (60.37M)
Net Income
(7.22M) (202.39M) (413.12M) (138.93M)
Net Income Growth
+85.84% -2,702.38% -104.12% +66.37%
Net Margin Growth
-3.24% -80.50% -163.81% -57.52%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(7.22M) (202.39M) (413.12M) (138.93M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(7.22M) (202.39M) (413.12M) (138.93M)
EPS (Basic)
-0.0714 -1.7948 -3.5419 -1.3027
EPS (Basic) Growth
+86.42% -2,413.73% -97.34% +63.22%
Basic Shares Outstanding
101.11M 112.76M 116.64M 106.65M
EPS (Diluted)
-0.0714 -1.7948 -3.5419 -1.3027
EPS (Diluted) Growth
+86.42% -2,413.73% -97.34% +63.22%
Diluted Shares Outstanding
101.11M 112.76M 116.64M 106.65M
EBITDA
20.75M 20.84M 41.93M 35.53M
EBITDA Growth
-49.70% +0.42% +101.19% -15.26%
EBITDA Margin
+9.32% +8.29% +16.62% +14.71%

Snapshot

Average Recommendation HOLD Average Target Price 2.464
Number of Ratings 11 Current Quarters Estimate 0.042
FY Report Date 06 / 2026 Current Year's Estimate 0.181
Last Quarter’s Earnings 0.06 Median PE on CY Estimate N/A
Year Ago Earnings 0.24 Next Fiscal Year Estimate 0.187
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 10 10 10 10
Mean Estimate 0.04 0.04 0.18 0.19
High Estimates 0.05 0.05 0.21 0.22
Low Estimate 0.04 0.04 0.17 0.15
Coefficient of Variance 8.13 10.96 8.01 14.05

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 3 3 2
OVERWEIGHT 0 0 0
HOLD 7 7 8
UNDERWEIGHT 0 0 0
SELL 1 1 1
MEAN Hold Hold Hold

Insider Actions for Definitive Healthcare Corp - DH

Date Name Shares Transaction Value
May 6, 2026 Jason Krantz Director 1,201,438 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $0.99 per share 1,189,423.62
May 6, 2026 Casey Heller Chief Financial Officer 2,005,853 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $0.99 per share 1,985,794.47
Mar 4, 2026 Kevin Coop Chief Executive Officer; Director 5,116,465 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $1.28 per share 6,549,075.20

Definitive Healthcare Corp in the News